Literature DB >> 34757768

SPRINT Revisited: Updated Results and Implications.

Jackson T Wright1, Paul K Whelton2, Karen C Johnson3, Joni K Snyder4, David M Reboussin5, William C Cushman3, Jeff D Williamson6, Nicholas M Pajewski5, Alfred K Cheung7, Cora E Lewis8, Suzanne Oparil9, Michael V Rocco10, Srinivasan Beddhu7, Lawrence J Fine4, Jeffrey A Cutler4, Walter T Ambrosius5, Mahboob Rahman1, Carolyn H Still11, Zhengyi Chen12, Curtis Tatsuoka12.   

Abstract

The SPRINT (Systolic Blood Pressure Intervention Trial) results have influenced clinical practice but have also generated discussion regarding the validity, generalizability, and importance of the findings. Following the SPRINT primary results manuscript in 2015, additional results and analyses of the data have addressed these concerns. The primary objective of this article is to respond to key questions that have been raised.

Entities:  

Keywords:  blood pressure; cardiovascular disease; controlled clinical trial; heart failure; hypertension; myocardial infarction

Mesh：

Substances：

Year:  2021        PMID： 34757768      PMCID： PMC8824314          DOI： 10.1161/HYPERTENSIONAHA.121.17682

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


  63 in total

1.  Redefining Blood-Pressure Targets--SPRINT Starts the Marathon.

Authors:  Vlado Perkovic; Anthony Rodgers
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245

2.  Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.

Authors:  Emmanuelle Vidal-Petiot; Ian Ford; Nicola Greenlaw; Roberto Ferrari; Kim M Fox; Jean-Claude Tardif; Michal Tendera; Luigi Tavazzi; Deepak L Bhatt; Philippe Gabriel Steg
Journal:  Lancet       Date:  2016-08-30       Impact factor: 79.321

3.  Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP.

Authors:  Leo F Buckley; Dave L Dixon; George F Wohlford; Dayanjan S Wijesinghe; William L Baker; Benjamin W Van Tassell
Journal:  Diabetes Care       Date:  2017-09-25       Impact factor: 19.112

4.  Attended Versus Unattended Blood Pressure Measurement in a Real Life Setting.

Authors:  Frederic Bauer; Felix S Seibert; Benjamin Rohn; Klaus A R Bauer; Eckart Rolshoven; Nina Babel; Timm H Westhoff
Journal:  Hypertension       Date:  2017-12-18       Impact factor: 10.190

5.  Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?

Authors:  Franz H Messerli; Giuseppe Mancia; C Richard Conti; Ann C Hewkin; Stuart Kupfer; Annette Champion; Rainer Kolloch; Athanase Benetos; Carl J Pepine
Journal:  Ann Intern Med       Date:  2006-06-20       Impact factor: 25.391

Review 6.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

Authors:  Dena Ettehad; Connor A Emdin; Amit Kiran; Simon G Anderson; Thomas Callender; Jonathan Emberson; John Chalmers; Anthony Rodgers; Kazem Rahimi
Journal:  Lancet       Date:  2015-12-24       Impact factor: 79.321

7.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

8.  Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions.

Authors:  Ilya M Nasrallah; Nicholas M Pajewski; Alexander P Auchus; Gordon Chelune; Alfred K Cheung; Maryjo L Cleveland; Laura H Coker; Michael G Crowe; William C Cushman; Jeffrey A Cutler; Christos Davatzikos; Lisa Desiderio; Jimit Doshi; Guray Erus; Larry J Fine; Sarah A Gaussoin; Darrin Harris; Karen C Johnson; Paul L Kimmel; Manjula Kurella Tamura; Lenore J Launer; Alan J Lerner; Cora E Lewis; Jennifer Martindale-Adams; Claudia S Moy; Linda O Nichols; Suzanne Oparil; Paula K Ogrocki; Mahboob Rahman; Stephen R Rapp; David M Reboussin; Michael V Rocco; Bonnie C Sachs; Kaycee M Sink; Carolyn H Still; Mark A Supiano; Joni K Snyder; Virginia G Wadley; Jennifer Walker; Daniel E Weiner; Paul K Whelton; Valerie M Wilson; Nancy Woolard; Jackson T Wright; Clinton B Wright; Jeff D Williamson; R Nick Bryan
Journal:  JAMA       Date:  2019-08-13       Impact factor: 56.272

9.  Unattended versus attended automated office blood pressure: Systematic review and meta-analysis of studies using the same methodology for both methods.

Authors:  Anastasios Kollias; Emelina Stambolliu; Konstantinos G Kyriakoulis; Areti Gravvani; George S Stergiou
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-12-25       Impact factor: 3.738

10.  Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.

Authors:  Srinivasan Beddhu; Jincheng Shen; Alfred K Cheung; Paul L Kimmel; Glenn M Chertow; Guo Wei; Robert E Boucher; Michel Chonchol; Farid Arman; Ruth C Campbell; Gabriel Contreras; Jamie P Dwyer; Barry I Freedman; Joachim H Ix; Kent Kirchner; Vasilios Papademetriou; Roberto Pisoni; Michael V Rocco; Paul K Whelton; Tom Greene
Journal:  J Am Soc Nephrol       Date:  2019-07-19       Impact factor: 10.121
View more
  1 in total

Review 1.  New wrinkles in hypertension management 2022.

Authors:  Robert M Carey; Paul K Whelton
Journal:  Curr Opin Cardiol       Date:  2022-07-01       Impact factor: 2.108
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.